Selective inhibition of stemness through EGFR/FOXA2/SOX9 axis reduces pancreatic cancer metastasis. Kaushik G, Seshacharyulu P, Rauth S, Nallasamy P, et al. Oncogene 2021;40:848-862.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kaushik G, Seshacharyulu P, Rauth S, Nallasamy P, et al. Selective inhibition of stemness through EGFR/FOXA2/SOX9 axis reduces pancreatic cancer metastasis. Oncogene 2021;40:848-862.
PMID: 33288882